{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:24:53Z","timestamp":1782311093103,"version":"3.54.5"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-024-02363-w","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T19:02:42Z","timestamp":1721070162000},"page":"2111-2141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Inositols and female reproduction disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)\u2014Women\u2019s Endocrinology"],"prefix":"10.1007","volume":"47","author":[{"given":"Costanzo","family":"Moretti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bonomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Dionese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Federici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Fulghesu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Giannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Guccione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Maseroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Moghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Mioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Pivonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Sabbadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Scaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Tonacchera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzia","family":"Verde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Vignozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2242-6734","authenticated-orcid":false,"given":"Alessandra","family":"Gambineri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"key":"2363_CR1","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.26355\/eurrev_202103_25279","volume":"25","author":"AK Kiani","year":"2021","unstructured":"Kiani AK, Paolacci S, Calogero AE, Cannarella R, Di Renzo GC, Gerli S, Della Morte C, Busetto GM, De Berbardinis E, Del Giudice F, Stuppia L, Facchinetti F, Dinicola S, Bertelli M (2021) From Myo-inositol to D-chiro-inositol molecular pathways. Eur Rev Med Pharmacol Sci 25:2390\u20132402. https:\/\/doi.org\/10.26355\/eurrev_202103_25279","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2363_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6306410","author":"AS Lagan\u00e0","year":"2016","unstructured":"Lagan\u00e0 AS, Rossetti P, Buscema M, La Vignera S, Condorelli RA, Gullo G, Granese R, Triolo O (2016) Metabolism and ovarian function in pcos women: a therapeutic approach with inositols. Int J Endocrinol. https:\/\/doi.org\/10.1155\/2016\/6306410","journal-title":"Int J Endocrinol"},{"key":"2363_CR3","doi-asserted-by":"publisher","first-page":"16904","DOI":"10.1016\/S0021-9258(18)41870-4","volume":"267","author":"Y Pak","year":"1992","unstructured":"Pak Y, Huang LC, Lilley KJ, Larner J (1992) In vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues. J Biol Chem 267:16904\u201316910 (PMID: 1387397)","journal-title":"J Biol Chem"},{"key":"2363_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/15604280212528","volume":"3","author":"J Larner","year":"2002","unstructured":"Larner J (2002) D-chiro-inositol\u2013its functional role in insulin action and its deficit in insulin resistance. Int J Exp Diabetes Res 3:47\u201360. https:\/\/doi.org\/10.1080\/15604280212528","journal-title":"Int J Exp Diabetes Res"},{"key":"2363_CR5","doi-asserted-by":"publisher","first-page":"10575","DOI":"10.3390\/ijms221910575","volume":"22","author":"S Dinicola","year":"2021","unstructured":"Dinicola S, Unfer V, Facchinetti F et al (2021) Inositols: from established knowledge to novel approaches. Int J Mol Sci 22:10575. https:\/\/doi.org\/10.3390\/ijms221910575","journal-title":"Int J Mol Sci"},{"key":"2363_CR6","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.3390\/nu13072210","volume":"13","author":"MPA Baldassarre","year":"2021","unstructured":"Baldassarre MPA, Di Tomo P, Centorame G, Pandolfi A, Di Pietro N, Consoli A, Formoso G (2021) Myoinositol reduces inflammation and oxidative stress in human endothelial cells exposed in vivo to chronic hyperglycemia. Nutrients 13:2210. https:\/\/doi.org\/10.3390\/nu13072210","journal-title":"Nutrients"},{"key":"2363_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/09513590.2013.860120","volume":"30","author":"A Pizzo","year":"2014","unstructured":"Pizzo A, Lagan\u00e0 AS, Barbaro L (2014) Comparison between effects of myo-inositol and d-chiro-inositol on ovarian function and metabolic factors in women with PCOS. Gynecol Endocrinol 30:205\u2013208. https:\/\/doi.org\/10.3109\/09513590.2013.860120","journal-title":"Gynecol Endocrinol"},{"key":"2363_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-23865-4_13","author":"F Facchinetti","year":"2016","unstructured":"Facchinetti F, Dante G, Neri I (2016) The ratio of MI to DCI and Its Impact in the treatment of polycystic ovary syndrome: experimental and literature evidences. Front Gynecol Endocrinol. https:\/\/doi.org\/10.1007\/978-3-319-23865-4_13","journal-title":"Front Gynecol Endocrinol"},{"key":"2363_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu15081875","volume":"15","author":"M Bizzarri","year":"2023","unstructured":"Bizzarri M, Monti N, Piombarolo A, Angeloni A, Verna R (2023) Myo-inositol and D-Chiro-inositol as modulators of ovary steroidogenesis: a narrative review. Nutrients 15:1\u201314. https:\/\/doi.org\/10.3390\/nu15081875","journal-title":"Nutrients"},{"key":"2363_CR10","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.bbamcr.2008.10.005","volume":"1793","author":"MJ Berridge","year":"2009","unstructured":"Berridge MJ (2009) Inositol trisphosphate and calcium signalling mechanisms. Biochim Biophys Acta 1793:933\u2013940. https:\/\/doi.org\/10.1016\/j.bbamcr.2008.10.005","journal-title":"Biochim Biophys Acta"},{"key":"2363_CR11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/s0022-3476(87)80561-9","volume":"110","author":"M Hallman","year":"1987","unstructured":"Hallman M, Arjomaa P, Hoppu K (1987) Inositol supplementation in respiratory distress syndrome: relationship between serum concentration, renal excretion, and lung effluent phospholipids. J Pediatr 110:604\u2013610. https:\/\/doi.org\/10.1016\/s0022-3476(87)80561-9","journal-title":"J Pediatr"},{"key":"2363_CR12","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1177\/1933719113518985","volume":"21","author":"V Unfer","year":"2014","unstructured":"Unfer V, Carlomagno G, Papaleo E, Vailati S, Candiani M, Baillargeon J-P (2014) Hyperinsulinemia alters myioinositol to d-chiroinositol ratio in the follicular fluid of of patients with PCOS. Reprod Sci 21:854\u2013858. https:\/\/doi.org\/10.1177\/1933719113518985","journal-title":"Reprod Sci"},{"issue":"435","key":"2363_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.tem.2020.02.002","volume":"31","author":"F Facchinetti","year":"2020","unstructured":"Facchinetti F, Unfer V, Dewailly D, Kamenov ZA, Diamanti-Kandarakis E, Lagan\u00e0 AS, Nestler JE, Soulage CO, Group of \u2019Inositol in PCOS and Reproduction (2020) Inositols in polycystic ovary syndrome: an overview on the advances. Trends Endocrinol Metab 31(435):447. https:\/\/doi.org\/10.1016\/j.tem.2020.02.002","journal-title":"Trends Endocrinol Metab"},{"key":"2363_CR14","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.26355\/eurrev_201712_13940","volume":"21","author":"K Ravanos","year":"2017","unstructured":"Ravanos K, Monastra G, Pavlidou T, Goudakou M, Prapas N (2017) Can high levels of D-chiro-inositol in follicular fluid exert detrimental effects in blastocyst quality? Eur Rev Med Pharmacol Sci 21:5491\u20135498. https:\/\/doi.org\/10.26355\/eurrev_201712_13940","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"P1","key":"2363_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1530\/EJE-14-0253","volume":"171","author":"G Conway","year":"2014","unstructured":"Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, Kelestimur F, Macut D, Micic D, Pasquali R, Pfeifer M, Pignatelli D, Pugeat M, Yildiz BO, ESE PCOS Special Interest Group (2014) The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol 171(P1):29. https:\/\/doi.org\/10.1530\/EJE-14-0253","journal-title":"Eur J Endocrinol"},{"key":"2363_CR16","doi-asserted-by":"publisher","first-page":"6296","DOI":"10.3390\/ijms24076296","volume":"24","author":"V Fedeli","year":"2023","unstructured":"Fedeli V, Catizone A, Querqui A, Unfer V, Bizzarri M (2023) The role of inositols in the Hyperandrogenic phenotypes of PCOS: a re-reading of larner\u2019s results. Int J Mol Sci 24:6296. https:\/\/doi.org\/10.3390\/ijms24076296","journal-title":"Int J Mol Sci"},{"key":"2363_CR17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3109\/09513590.2015.1054802","volume":"31","author":"JE Nestler","year":"2015","unstructured":"Nestler JE, Unfer V (2015) Reflections of inositol(s) for PCOS therapy: steps toward success. Gynecol Endocrinol 31:501\u2013505. https:\/\/doi.org\/10.3109\/09513590.2015.1054802","journal-title":"Gynecol Endocrinol"},{"key":"2363_CR18","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.febslet.2015.03.012","volume":"589","author":"S Scheider","year":"2015","unstructured":"Scheider S (2015) Inositol transport proteins. FEBS Lett 589:1049\u20131058. https:\/\/doi.org\/10.1016\/j.febslet.2015.03.012","journal-title":"FEBS Lett"},{"key":"2363_CR19","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/ph14060504","volume":"14","author":"R Gambioli","year":"2021","unstructured":"Gambioli R, Forte G, Buzzaccarini G, Unfer V, Lagan\u00e0 AS (2021) Myo-inositol as a key supporter of fertility and physiological gestation. Pharmaceuticals 14:504. https:\/\/doi.org\/10.3390\/ph14060504","journal-title":"Pharmaceuticals"},{"key":"2363_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.660381","author":"G Monastra","year":"2021","unstructured":"Monastra G, Vucenik I, Harrath AH, Alwasel SH, Kamenov ZA, Lagan\u00e0 AS, Monti N, Fedeli V, Bizzarri M (2021) PCOS and inositols: controversial results and necessary clarifications. Basic Differ Between D-Chiro and Myo-Inositol Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2021.660381","journal-title":"Basic Differ Between D-Chiro and Myo-Inositol. Front Endocrinol (Lausanne)"},{"key":"2363_CR21","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1210\/jc.2007-1907","volume":"93","author":"BA Swiglo","year":"2008","unstructured":"Swiglo BA, Murad MH, Sch\u00fcnemann HJ, Kunz R, Vigersky RA, Guyatt GH, Montori VM (2008) A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endocrinol Metab 93:666\u2013673. https:\/\/doi.org\/10.1210\/jc.2007-1907","journal-title":"J Clin Endocrinol Metab"},{"key":"2363_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1089\/thy.2020.0333","volume":"31","author":"P Van Trotsenburg","year":"2021","unstructured":"Van Trotsenburg P, Stoupa A, L\u00e9ger J, Rohrer T, Peters C, Fugazzola L, Cassio A, Heinrichs C, Beauloye V, Pohlenz J, Rodien P, Coutant R, Szinnai G, Murray P, Bart\u00e9s B, Luton D, Salerno M, de Sanctis L, Vigone M, Krude H, Persani L, Polak M (2021) Congenital Hypothyroidism: a 2020\u20132021 consensus guidelines update-an endo-european reference network initiative endorsed by the European society for pediatric endocrinology and the European society for endocrinology. Thyroid 31:387\u2013419. https:\/\/doi.org\/10.1089\/thy.2020.0333","journal-title":"Thyroid"},{"key":"2363_CR23","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1210\/jc.2015-4275","volume":"101","author":"A Jaye","year":"2016","unstructured":"Jaye A, Zhilin L, Yi Athena R, Wang-Song W, Wei Z, Shlomit K, Clifford L, Cecilia V, William G, JoAnne R (2016) Enhanced inflammatory transcriptome in the granulosa cells of women with polycystic ovarian syndrome. J Clin Endocrinol Metab 101:3459\u20133468. https:\/\/doi.org\/10.1210\/jc.2015-4275","journal-title":"J Clin Endocrinol Metab"},{"key":"2363_CR24","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi C, Garagnani P, Parini P, Giuliani C (2018) Santoro A (2018) Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol 14:576\u2013590. https:\/\/doi.org\/10.1038\/s41574-018-0059-4","journal-title":"Nat Rev Endocrinol"},{"key":"2363_CR25","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1080\/09513590.2017.1296127","volume":"33","author":"\u00d6 Emek\u00e7i \u00d6zlen","year":"2017","unstructured":"Emek\u00e7i \u00d6zlen \u00d6, Ali Cenk \u00d6, Erkan \u00c7, Recep Emre O, B\u00fclent G (2017) Myo-inositol administration positively effects ovulation induction and intrauterine insemination in patients with polycystic ovary syndrome: a prospective, controlled, randomized trial. Gynecol Endocrinol 33:524\u2013528. https:\/\/doi.org\/10.1080\/09513590.2017.1296127","journal-title":"Gynecol Endocrinol"},{"key":"2363_CR26","doi-asserted-by":"publisher","DOI":"10.1080\/174252551828344","author":"F Facchinetti","year":"2020","unstructured":"Facchinetti F, Cavalli P, Copp AJ, D\u2019Anna R, Kandaraki E, Greene NDE, Experts Group on Inositol in Basic and Clinical Research (2020) Unfer V 2020 An update on the use of inositols in preventing gestational diabetes mellitus (GDM) and neural tube defects (NTDs). Expert Opin Drug Metab Toxicol. https:\/\/doi.org\/10.1080\/174252551828344","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2363_CR27","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/jcph.362","volume":"54","author":"S Dinicola","year":"2014","unstructured":"Dinicola S, Chiu TT, Unfer V, Carlomagno G, Bizzarri M (2014) The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome. J Clin Pharmacol 54:1079\u20131092. https:\/\/doi.org\/10.1002\/jcph.362","journal-title":"J Clin Pharmacol"},{"key":"2363_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1507\/endocrj.ej13-0423","volume":"61","author":"D Heimark","year":"2014","unstructured":"Heimark D, McAllister J, Larner J (2014) Decreased myo-inositol to chiro-inositol (M\/C) ratios and increased M\/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls. Endocr J 61:111\u2013117. https:\/\/doi.org\/10.1507\/endocrj.ej13-0423","journal-title":"Endocr J"},{"key":"2363_CR29","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/humrep\/16.6.1255","volume":"16","author":"S Kirchengast","year":"2001","unstructured":"Kirchengast S, Huber J (2001) Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod 16:1255\u20131260. https:\/\/doi.org\/10.1093\/humrep\/16.6.1255","journal-title":"Hum Reprod"},{"key":"2363_CR30","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1093\/humrep\/deu096","volume":"29","author":"U Ezeh","year":"2014","unstructured":"Ezeh U, Pall M, Mathur R, Azziz R (2014) Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome. Hum Reprod 29:1508\u20131517. https:\/\/doi.org\/10.1093\/humrep\/deu096","journal-title":"Hum Reprod"},{"key":"2363_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/09513590801893232","volume":"24","author":"AD Genazzani","year":"2008","unstructured":"Genazzani AD, Lanzoni C, Ricchieri F, Jasonni VM (2008) Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. Gynecol Endocrinol 24:139\u2013144. https:\/\/doi.org\/10.1080\/09513590801893232","journal-title":"Gynecol Endocrinol"},{"key":"2363_CR32","first-page":"151","volume":"7","author":"S Gerli","year":"2003","unstructured":"Gerli S, Mignosa M, Di Renzo GC (2003) Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial. Eur Rev Med Pharmacol Sci 7:151\u2013159","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2363_CR33","first-page":"105","volume":"13","author":"D Costantino","year":"2009","unstructured":"Costantino D, Minozzi G, Minozzi E, Guaraldi C (2009) Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial. Eur Rev Med Pharmacol Sci 13:105\u2013110","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2363_CR34","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1080\/09513590701672405","volume":"23","author":"E Papaleo","year":"2007","unstructured":"Papaleo E, Unfer V, Baillargeon JP, De Santis L, Fusi F, Brigante C, Marelli G, Cino I, Redaelli A, Ferrari A (2007) Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecol Endocrinol 23:700\u2013703. https:\/\/doi.org\/10.1080\/09513590701672405","journal-title":"Gynecol Endocrinol"},{"key":"2363_CR35","doi-asserted-by":"publisher","DOI":"10.51273\/esc20.2516310","author":"NS Ikram-u-Allah","year":"2020","unstructured":"Ikram-u-Allah NS, Qaiser Javed I, Shazia Z, Tayyiba W (2020) Myoinositol in restoring spontaneous ovarian activity in patients with polycystic ovarian syndrome (PCOS). Esculapio. https:\/\/doi.org\/10.51273\/esc20.2516310","journal-title":"Esculapio"},{"key":"2363_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3109\/09513590.2014.964640","volume":"31","author":"Z Kamenov","year":"2015","unstructured":"Kamenov Z, Kolarov G, Gateva A, Carlomagno G, Genazzani AD (2015) Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance. Gynecol Endocrinol 31:131\u2013135. https:\/\/doi.org\/10.3109\/09513590.2014.964640","journal-title":"Gynecol Endocrinol"},{"key":"2363_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9537632","author":"PA Regidor","year":"2016","unstructured":"Regidor PA, Schindler AE (2016) Myoinositol as a safe and alternative approach in the treatment of infertile PCOS women: a German observational study. Int J Endocrinol. https:\/\/doi.org\/10.1155\/2016\/9537632","journal-title":"Int J Endocrinol"},{"key":"2363_CR38","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1056\/NEJM199904293401703","volume":"340","author":"JE Nestler","year":"1999","unstructured":"Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G (1999) Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N Engl J Med 340:1314\u20131320. https:\/\/doi.org\/10.1056\/NEJM199904293401703","journal-title":"N Engl J Med"},{"key":"2363_CR39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4158\/EP.8.6.417","volume":"8","author":"MJ Iuorno","year":"2002","unstructured":"Iuorno MJ, Jakubowicz DJ, Baillargeon JP, Dillon P, Gunn RD, Allan G, Nestler JE (2002) Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome. Endocr Pract 8:417\u2013423. https:\/\/doi.org\/10.4158\/EP.8.6.417","journal-title":"Endocr Pract"},{"key":"2363_CR40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3109\/09513590.2014.964201","volume":"31","author":"A La Marca","year":"2015","unstructured":"La Marca A, Grisendi V, Dondi G, Sighinolfi G, Cianci A (2015) The menstrual cycle regularization following D-chiro-inositol treatment in PCOS women: a retrospective study. Gynecol Endocrinol 31:52\u201356. https:\/\/doi.org\/10.3109\/09513590.2014.964201","journal-title":"Gynecol Endocrinol"},{"key":"2363_CR41","first-page":"321","volume":"67","author":"C Formuso","year":"2015","unstructured":"Formuso C, Stracquadanio M, Ciotta L (2015) Myo-inositol vs. D-chiro inositol in PCOS treatment. Minerva Ginecol 67:321\u2013325","journal-title":"Minerva Ginecol"},{"key":"2363_CR42","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.26355\/eurrev_201903_17278","volume":"23","author":"M Le Donne","year":"2019","unstructured":"Le Donne M, Metro D, Alibrandi A, Papa M, Benvenga S (2019) Effects of three treatment modalities (diet, myoinositol or myoinositol associated with D-chiro-inositol) on clinical and body composition outcomes in women with polycystic ovary syndrome. Eur Rev Med Pharmacol Sci 23:2293\u20132301. https:\/\/doi.org\/10.26355\/eurrev_201903_17278","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2363_CR43","doi-asserted-by":"publisher","first-page":"9387","DOI":"10.1002\/jcp.27623","volume":"234","author":"A Bevilacqua","year":"2019","unstructured":"Bevilacqua A, Dragotto J, Giuliani A, Bizzarri M (2019) Myo-inositol and D-chiro-inositol (40:1) reverse histological and functional features of polycystic ovary syndrome in a mouse model. J Cell Physiol 234:9387\u20139398. https:\/\/doi.org\/10.1002\/jcp.27623","journal-title":"J Cell Physiol"},{"key":"2363_CR44","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.26355\/eurrev_201906_18223","volume":"23","author":"M Nordio","year":"2019","unstructured":"Nordio M, Basciani S, Camajani E (2019) The 40:1 myo-inositol\/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios. Eur Rev Med Pharmacol Sci 23:5512\u20135521. https:\/\/doi.org\/10.26355\/eurrev_201906_18223","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2363_CR45","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.18203\/2320-1770.ijrcog20171563","volume":"6","author":"C Kishan","year":"2017","unstructured":"Kishan C, Sujata M, Sandhya B (2017) A randomised clinical trial comparing myoinositol and metformin in PCOS. Int J Reprod Contracept Obstet Gynecol 6:1814\u20131820. https:\/\/doi.org\/10.18203\/2320-1770.ijrcog20171563","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"2363_CR46","doi-asserted-by":"publisher","first-page":"348","DOI":"10.4103\/jhrs.JHRS_59_17","volume":"11","author":"N Chhabra","year":"2018","unstructured":"Chhabra N, Malik S (2018) Effect of insulin sensitizers on raised serum anti-mullerian hormone levels in infertile women with polycystic ovarian syndrome. J Hum Reprod Sci 11:348\u2013352. https:\/\/doi.org\/10.4103\/jhrs.JHRS_59_17","journal-title":"J Hum Reprod Sci"},{"key":"2363_CR47","doi-asserted-by":"publisher","DOI":"10.5455\/2320-1770.ijrcog20150234","author":"R Angik","year":"2015","unstructured":"Angik R, Jajoo SS, Hariharan C, Chimote A (2015) A comparative study of metabolic and hormonal effects of myoinositol vs. metformin in women with polycystic ovary syndrome: a randomised controlled trial. Int J Reprod Contracept Obstet Gynecol. https:\/\/doi.org\/10.5455\/2320-1770.ijrcog20150234","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"2363_CR48","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s.00404-029-05064-5","volume":"299","author":"S Pourghasem","year":"2019","unstructured":"Pourghasem S, Bazarganipour F, Taghavi SA et al (2019) The effectiveness of inositol and metformin on infertile polycystic ovary syndrome women with resistant to letrozole. Arch Gynecol Obstet 299:1193\u20131199. https:\/\/doi.org\/10.1007\/s.00404-029-05064-5","journal-title":"Arch Gynecol Obstet"},{"key":"2363_CR49","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3109\/09513590903366996","volume":"26","author":"E Raffone","year":"2010","unstructured":"Raffone E, Rizzo P, Benedetto V (2010) Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women. Gynecol Endocrinol 26:275\u2013280. https:\/\/doi.org\/10.3109\/09513590903366996","journal-title":"Gynecol Endocrinol"},{"key":"2363_CR50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/09513590.2016.1236078","volume":"33","author":"F Fruzzetti","year":"2017","unstructured":"Fruzzetti F, Perini D, Russo M, Bucci F, Gadducci A (2017) Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS). Gynecol Endocrinol 33:39\u201342. https:\/\/doi.org\/10.1080\/09513590.2016.1236078","journal-title":"Gynecol Endocrinol"},{"key":"2363_CR51","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15510","author":"A Bahadur","year":"2021","unstructured":"Bahadur A, Arora H, Ravi AK, Naithani M, Bahurupi Y, Chaturvedi J, Ajmani M, Mundhra R (2021) Comparison of clinical metabolic and hormonal effects of metformin versus, combined therapy of metformin with Myoinositol plus d-Chiro-inositol in women with polycystic ovary syndrome (pcos): a randomized controlled trial. Cureus. https:\/\/doi.org\/10.7759\/cureus.15510","journal-title":"Cureus"},{"issue":"2","key":"2363_CR52","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/cen.14931","volume":"99","author":"R Nazirudeen","year":"2023","unstructured":"Nazirudeen R, Sridhar S, Priyanka R, Sumathi B, Natarajan V, Subbiah E, Raghavan KS, Sangumani J (2023) A randomized controlled trial comparing myoinositol with metformin versus metformin monotherapy in polycystic ovary syndrome. Clin Endocrinol (Oxf) 99(2):198\u2013205. https:\/\/doi.org\/10.1111\/cen.14931","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2363_CR53","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/humrep\/deg113","volume":"18","author":"TT Chiu","year":"2003","unstructured":"Chiu TT, Rogers MS, Briton-Jones C, Haines C (2003) Effects of myo-inositol on the in-vitro maturation and subsequent development of mouse oocytes. Hum Reprod 18:408\u2013416. https:\/\/doi.org\/10.1093\/humrep\/deg113","journal-title":"Hum Reprod"},{"issue":"2","key":"2363_CR54","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","volume":"189","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, Redman LM, Boyle JA, Norman RJ, Mousa A, Joham AE, International PCOS Network (2023) Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Eur J Endocrinol 189(2):G43\u2013G64. https:\/\/doi.org\/10.1093\/ejendo\/lvad096","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2363_CR55","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.fertnstert.2008.01.088","volume":"91","author":"E Papaleo","year":"2009","unstructured":"Papaleo E, Unfer V, Baillargeon JP, Fusi F, Occhi F, Santis De (2009) Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles, A prospective, controlled, randomized trial. Fertil Steril 91(5):1750\u20131754. https:\/\/doi.org\/10.1016\/j.fertnstert.2008.01.088","journal-title":"Fertil Steril"},{"issue":"5","key":"2363_CR56","first-page":"509","volume":"15","author":"L Ciotta","year":"2011","unstructured":"Ciotta L, Stracquadanio M, Pagano I, Carbonaro A, Palumbo M, Gulino M (2011) Effects of myo-inositol supplementation on oocyte\u2019s quality in PCOS patients: a double blind trial. Eur Rev Med Pharmacol Sci 15(5):509\u2013514","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"2363_CR57","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3109\/09513590.2012.743020","volume":"29","author":"PG Artini","year":"2013","unstructured":"Artini PG, Di Berardino OM, Papini F, Genazzani AD, Simi G, Ruggiero M, Cela V (2013) Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A Randomized stud Gynecol Endocrinol 29(4):375\u2013379. https:\/\/doi.org\/10.3109\/09513590.2012.743020","journal-title":"A Randomized stud Gynecol Endocrinol"},{"issue":"1","key":"2363_CR58","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3109\/09513590.2015.1101444.60","volume":"32","author":"A Pacchiarotti","year":"2016","unstructured":"Pacchiarotti A, Carlomagno G, Antonini G, Pacchiarotti A (2016) Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome. Gynecol Endocrinol 32(1):69\u201373. https:\/\/doi.org\/10.3109\/09513590.2015.1101444.60","journal-title":"Gynecol Endocrinol"},{"key":"2363_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012378.pub2","author":"MG Showell","year":"2018","unstructured":"Showell MG, Mackenzie-Proctor R, Jordan V, Hodgson R, Farquhar C (2018) Inositol for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD012378.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"2363_CR60","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.rbmo.2017.07.005","volume":"35","author":"N Mendoza","year":"2017","unstructured":"Mendoza N, Perez L, Simoncini T, Genazzani A (2017) Inositol supplementation in women with polycystic ovary syndrome undergoing intracytoplasmatic sperm injection: a systematic review and meta-analysis of randomized controlled trials. Reprod Biomed Online 35:529\u2013535. https:\/\/doi.org\/10.1016\/j.rbmo.2017.07.005","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"2363_CR61","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00404-018-4861-y","volume":"298","author":"AS Lagan\u00e0","year":"2018","unstructured":"Lagan\u00e0 AS, Vitagliano A, Noventa M, Ambrosini G, D\u2019Anna R (2018) Myo-inositol supplementation reduces the amount of gonadotropins and length of ovarian stimulation in women undergoing IVF: a systematic review and meta-analysis of randomized controlled trials. Arch Gynecol Obstet 298(4):675\u2013684. https:\/\/doi.org\/10.1007\/s00404-018-4861-y","journal-title":"Arch Gynecol Obstet"},{"issue":"10","key":"2363_CR62","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/aogs.13625","volume":"98","author":"P Bhide","year":"2019","unstructured":"Bhide P, Jyotsna P, Anil G, Amit S, Roy H, Ganesh A (2019) Effect of myo-inositol\/di-chiro-inositol on markers of ovarian reserve in women with PCOS undergoing IVF\/ICSI: A systematic review and meta-analysis. Acta Obstet Gynecol Scand 98(10):1235\u20131244. https:\/\/doi.org\/10.1111\/aogs.13625","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2363_CR63","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1477-7827-10-52","volume":"10","author":"F Lisi","year":"2012","unstructured":"Lisi F, Carfagna P, Oliva MM, Rago R, Lisi R, Poverini R, Manna C, Vaquero E, Caserta D, Raparelli V, Marci R, Moscarini M (2012) Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study. Reprod Biol Endocrinol 10:52. https:\/\/doi.org\/10.1186\/1477-7827-10-52","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"2363_CR64","first-page":"38","volume":"24","author":"R Schillaci","year":"2012","unstructured":"Schillaci R, Mangione D, Lo Monte G, Vassiliadis A (2012) Inositol supplementation and IVF outcome: preliminary data. J Gynaecol Obstet 24(1):38\u201344","journal-title":"J Gynaecol Obstet"},{"key":"2363_CR65","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008842","author":"X Zheng","year":"2017","unstructured":"Zheng X, Lin D, Zhang Y, Lin Y, Song J, Li S, Sun Y (2017) Inositol supplement improves clinical pregnancy rate in infertile women undergoing ovulation induction for ICSI or IVF-ET. Medicine (Baltimore). https:\/\/doi.org\/10.1097\/MD.0000000000008842","journal-title":"Medicine (Baltimore)"},{"key":"2363_CR66","first-page":"3095","volume":"17","author":"GF Brusco","year":"2013","unstructured":"Brusco GF, Mariani M (2013) Inositol: effects on oocyte quality in patients undergoing ICSI. an open study. Eur Rev Med Pharmacol Sci 17:3095\u20133102 (PMID: 24302192)","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2363_CR67","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13048-015-0167-x","volume":"8","author":"F Caprio","year":"2015","unstructured":"Caprio F, D\u2019Eufemia MD, Trotta C, Campitiello MR, Ianniello R, Mele D, Colacurci N (2015) Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial. J Ovarian Re 8:37. https:\/\/doi.org\/10.1186\/s13048-015-0167-x","journal-title":"J Ovarian Re"},{"issue":"4","key":"2363_CR68","first-page":"452","volume":"15","author":"V Unfer","year":"2011","unstructured":"Unfer V, Carlomagno G, Rizzo P, Raffone E, Roseff S (2011) Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Eur Rev Med Pharmacol Sci 15(4):452\u2013457","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"2363_CR69","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12958-023-01055-z","volume":"21","author":"D Greff","year":"2023","unstructured":"Greff D, Juh\u00e1sz AE, V\u00e1ncsa S, V\u00e1radi A, Sipos Z, Szinte J, Park S, Hegyi P, Nyir\u00e1dy P, \u00c1cs N, V\u00e1rb\u00edr\u00f3 S, Horv\u00e1th EM (2023) Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Reprod Biol Endocrinol 21(1):10. https:\/\/doi.org\/10.1186\/s12958-023-01055-z","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"2363_CR70","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/GRF.0b013e31815a5494","volume":"50","author":"KY Lain","year":"2007","unstructured":"Lain KY, Catalano PM (2007) Metabolic changes in pregnancy. Clin Obstet Gynecol 50(4):938\u2013948. https:\/\/doi.org\/10.1097\/GRF.0b013e31815a5494","journal-title":"Clin Obstet Gynecol"},{"issue":"3","key":"2363_CR71","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1172\/JCI24531","volume":"115","author":"TA Buchanan","year":"2005","unstructured":"Buchanan TA, Xiang AH (2005) Gestational diabetes mellitus. J Clin Invest 115(3):485\u2013491. https:\/\/doi.org\/10.1172\/JCI24531","journal-title":"J Clin Invest"},{"issue":"4","key":"2363_CR72","doi-asserted-by":"publisher","first-page":"780","DOI":"10.2337\/dc11-1790","volume":"35","author":"PM Catalano","year":"2012","unstructured":"Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR, Metzger BE, Lowe LP, Trimble ER, Coustan DR, Hadden DR, Persson B, Hod M, Oats JJN (2012) The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care 35(4):780\u2013786. https:\/\/doi.org\/10.2337\/dc11-1790","journal-title":"Diabetes Care"},{"key":"2363_CR73","doi-asserted-by":"publisher","first-page":"123","DOI":"10.7326\/0003-4819-159-2-201307160-00661","volume":"159","author":"L Hartling","year":"2013","unstructured":"Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Donovan L (2013) Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. preventive services task force and the national institutes of health office of medical applications of research. Ann Intern Med 159:123\u2013129. https:\/\/doi.org\/10.7326\/0003-4819-159-2-201307160-00661","journal-title":"Ann Intern Med"},{"key":"2363_CR74","doi-asserted-by":"publisher","first-page":"854","DOI":"10.2337\/dc12-1371","volume":"36","author":"R D'Anna","year":"2013","unstructured":"D\u2019Anna R, Scilipoti A, Giordano D, Caruso C, Cannata ML, Interdonato ML, Corrado F, Di Benedetto A (2013) Myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study. Diabetes Care 36:854\u2013857. https:\/\/doi.org\/10.2337\/dc12-1371","journal-title":"Diabetes Care"},{"issue":"10","key":"2363_CR75","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3109\/14767058.2013.766691","volume":"26","author":"B Matarrelli","year":"2013","unstructured":"Matarrelli B, Vitacolonna E, D\u2019Angelo M, Pavone G, Mattei PA, Liberati M, Celentano C (2013) Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. J Matern Fetal Neonatal Med 26(10):967\u2013972. https:\/\/doi.org\/10.3109\/14767058.2013.766691","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"2363_CR76","first-page":"270","volume":"18","author":"A Malvasi","year":"2014","unstructured":"Malvasi A, Casciaro F, Minervini MM, Kosmas I, Mynbaev OA, Pacella E, Monti Condesnitt V, Creanza A, Di Renzo GC, Tinelli A (2014) Myo-inositol, D-chiro-inositol, folic acid and manganese in second trimester of pregnancy: a preliminary investigation. Eur Rev Med Pharmacol Sci 18(2):270\u2013274 (PMID: 24488919)","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2363_CR77","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/AOG.0000000000000958","volume":"126","author":"R D'Anna","year":"2015","unstructured":"D\u2019Anna R, Di Benedetto A, Scilipoti A, Santamaria A, Interdonato ML, Petrella E, Neri I, Pintaudi B, Corrado F, Facchinetti F (2015) Myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women: a randomized controlled trial. Obstet Gynecol 126:310\u2013315. https:\/\/doi.org\/10.1097\/AOG.0000000000000958","journal-title":"Obstet Gynecol"},{"issue":"19","key":"2363_CR78","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.3109\/14767058.2015.1121478","volume":"29","author":"A Santamaria","year":"2016","unstructured":"Santamaria A, Di Benedetto A, Petrella E, Pintaudi B, Corrado F, D\u2019Anna R, Neri I, Facchinetti F (2016) Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial. J Matern Fetal Neonatal Med 29(19):3234\u20133237. https:\/\/doi.org\/10.3109\/14767058.2015.1121478","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"2363_CR79","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2337\/dc16-2449","volume":"40","author":"M Farren","year":"2017","unstructured":"Farren M, Daly N, McKeating A, Kinsley B, Turner MJ, Daly S (2017) The Prevention of gestational diabetes mellitus with antenatal oral inositol supplementation: a randomized controlled trial. Diabetes Care 40(6):759\u2013763. https:\/\/doi.org\/10.2337\/dc16-2449","journal-title":"Diabetes Care"},{"issue":"5","key":"2363_CR80","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1080\/14767058.2018.1500545","volume":"33","author":"C Celentano","year":"2020","unstructured":"Celentano C, Matarrelli B, Pavone G, Vitacolonna E, Mattei PA, Berghella V, Liberati M (2020) The influence of different inositol stereoisomers supplementation in pregnancy on maternal gestational diabetes mellitus and fetal outcomes in high-risk patients: a randomized controlled trial. J Matern Fetal Neonatal Med 33(5):743\u2013751. https:\/\/doi.org\/10.1080\/14767058.2018.1500545","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"2363_CR81","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1080\/09637486.2020.1852191","volume":"72","author":"SG Vitale","year":"2021","unstructured":"Vitale SG, Corrado F, Caruso S, Di Benedetto A, Giunta L, Cianci A, D\u2019Anna R (2021) Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes - a randomized and open-label, placebo-controlled clinical trial. Int J Food Sci Nutr 72(5):670\u2013679. https:\/\/doi.org\/10.1080\/09637486.2020.1852191","journal-title":"Int J Food Sci Nutr"},{"issue":"5","key":"2363_CR82","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.2337\/dc20-2515","volume":"44","author":"KM Godfrey","year":"2021","unstructured":"Godfrey KM, Barton SJ, El-Heis S, Kenealy T, Nield H, Baker PN, Chong YS, Cutfield W, Chan SY, NiPPeR Study Group (2021) Myo-inositol, probiotics, and micronutrient supplementation from preconception for glycemia in pregnancy: NiPPeR international multicenter double-blind randomized controlled trial. Diabetes Care 44(5):1091\u20131099. https:\/\/doi.org\/10.2337\/dc20-2515","journal-title":"Diabetes Care"},{"key":"2363_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2022.100714","author":"SY Chan","year":"2022","unstructured":"Chan SY, Yong HEJ, Chang HF, Barton SJ, Galani S, Zhang H, Wong JT, Ong J, Ebreo M, El-Heis S, Kenealy T, Nield H, Baker PN, Chong YS, Cutfield WS, Godfrey KM, NiPPeR Study Group (2022) Peripartum outcomes after combined myo-inositol, probiotics, and micronutrient supplementation from preconception: the NiPPeR randomized controlled trial. Am J Obstet Gynecol MFM. https:\/\/doi.org\/10.1016\/j.ajogmf.2022.100714","journal-title":"Am J Obstet Gynecol MFM"},{"key":"2363_CR84","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-050110","author":"CE Amaefule","year":"2022","unstructured":"Amaefule CE, Drymoussi Z, Gonzalez Carreras FJ, Pardo Llorente MDC, Lanz D, Dodds J, Sweeney L, Pizzo E, Thomas A, Heighway J, Daru J, Sobhy S, Poston L, Khalil A, Myers J, Harden A, Hitman G, Khan KS, Zamora J, P\u00e9rez T, Huda MSB, Thangaratinam S (2022) Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative study. BMJ Open. https:\/\/doi.org\/10.1136\/bmjopen-2021-050110","journal-title":"BMJ Open"},{"issue":"4","key":"2363_CR85","doi-asserted-by":"publisher","first-page":"357","DOI":"10.23736\/S2724-606X.22.05036-9","volume":"75","author":"S Esmaeilzadeh","year":"2023","unstructured":"Esmaeilzadeh S, Ghadimi R, Mashayekh-Amiri S, Delavar MA, Basirat Z (2023) The effect of myo-inositol supplementation on the prevention of gestational diabetes in overweight pregnant women: a randomized, double-blind, controlled trial. Minerva Obstet Gynecol 75(4):357\u2013364. https:\/\/doi.org\/10.23736\/S2724-606X.22.05036-9","journal-title":"Minerva Obstet Gynecol"},{"issue":"2","key":"2363_CR86","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3892\/br.2017.939","volume":"7","author":"D Dell'Edera","year":"2017","unstructured":"Dell\u2019Edera D, Sarlo F, Allegretti A, Simone F, Lupo MG, Epifania AA (2017) The influence of D-chiro-inositol and D-myo-inositol in pregnant women with glucose intolerance. Biomed Rep 7(2):169\u2013172. https:\/\/doi.org\/10.3892\/br.2017.939","journal-title":"Biomed Rep"},{"issue":"14","key":"2363_CR87","first-page":"3305","volume":"21","author":"D Dell'Edera","year":"2017","unstructured":"Dell\u2019Edera D, Sarlo F, Allegretti A, Epifania AA, Simone F, Lupo MG, Benedetto M, D\u2019Apice MR, Capalbo A (2017) Prevention of neural tube defects and maternal gestational diabetes through the inositol supplementation: preliminary results. Eur Rev Med Pharmacol Sci 21(14):3305\u20133311 (PMID: 28770950)","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"2363_CR88","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3109\/09513590.2011.633665","volume":"28","author":"R D'Anna","year":"2012","unstructured":"D\u2019Anna R, Di Benedetto V, Rizzo P, Raffone E, Interdonato ML, Corrado F, Di Benedetto A (2012) Myo-inositol may prevent gestational diabetes in PCOS women. Gynecol Endocrinol 28(6):440\u2013442. https:\/\/doi.org\/10.3109\/09513590.2011.633665","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"2363_CR89","doi-asserted-by":"publisher","first-page":"300.e1","DOI":"10.1016\/j.ajog.2018.05.018","volume":"219","author":"A Santamaria","year":"2018","unstructured":"Santamaria A, Alibrandi A, Di Benedetto A, Pintaudi B, Corrado F, Facchinetti F, D\u2019Anna R (2018) Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs. Am J Obstet Gynecol 219(3):300.e1-300.e6. https:\/\/doi.org\/10.1016\/j.ajog.2018.05.018","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"2363_CR90","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/j.1464-5491.2011.03284.x","volume":"28","author":"F Corrado","year":"2011","unstructured":"Corrado F, D\u2019Anna R, Di Vieste G, Giordano D, Pintaudi B, Santamaria A, Di Benedetto A (2011) The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabet Med 28(8):972\u2013975. https:\/\/doi.org\/10.1111\/j.1464-5491.2011.03284.x","journal-title":"Diabet Med"},{"key":"2363_CR91","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00592-018-1157-4","volume":"55","author":"F Fraticelli","year":"2018","unstructured":"Fraticelli F, Celentano C, Zecca IA, Di Vieste G, Pintaudi B, Liberati M, Franzago M, Di Nicola M, Vitacolonna E (2018) Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial. Acta Diabetol 55:805\u2013812. https:\/\/doi.org\/10.1007\/s00592-018-1157-4","journal-title":"Acta Diabetol"},{"issue":"1","key":"2363_CR92","doi-asserted-by":"publisher","first-page":"8866","DOI":"10.1038\/s41598-021-88329-x","volume":"11","author":"R D'Anna","year":"2021","unstructured":"D\u2019Anna R, Corrado F, Loddo S, Gullo G, Giunta L, Di Benedetto A (2021) Myoinositol plus \u03b1-lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study. Sci Rep 11(1):8866. https:\/\/doi.org\/10.1038\/s41598-021-88329-x","journal-title":"Sci Rep"},{"key":"2363_CR93","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ejogrb.2021.02.017","volume":"260","author":"V Kulshrestha","year":"2021","unstructured":"Kulshrestha V, Balani S, Kachhawa G, Vanamail P, Kumari R, Sharma JB, Bhatla N (2021) Efficacy of myoinositol in treatment of gestational diabetes mellitus in Asian Indian women: a pilot randomized clinical trial. Eur J Obstet Gynecol Reprod Biol 260:42\u201347. https:\/\/doi.org\/10.1016\/j.ejogrb.2021.02.017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2363_CR94","doi-asserted-by":"publisher","first-page":"5846286","DOI":"10.1155\/2017\/5846286","volume":"2017","author":"P Cavalli","year":"2017","unstructured":"Cavalli P, Ronda E (2017) Myoinositol: the bridge (ponti) to reach a healthy pregnancy. Int J Endocrinol 2017:5846286. https:\/\/doi.org\/10.1155\/2017\/5846286","journal-title":"Int J Endocrinol"},{"key":"2363_CR95","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1093\/humrep\/17.9.2451","volume":"17","author":"P Cogram","year":"2002","unstructured":"Cogram P, Tesh S, Tesh J, Wade A, Allan G, Greene ND, Copp AJ (2002) D-chiro-inositol is more effective than myo-inositol in preventing folate-resistant mouse neural tube defects. Hum Reprod 17:2451\u20132458. https:\/\/doi.org\/10.1093\/humrep\/17.9.2451","journal-title":"Hum Reprod"},{"issue":"12","key":"2363_CR96","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1080\/17425255.2020.1828344","volume":"16","author":"F Facchinetti","year":"2020","unstructured":"Facchinetti F, Cavalli P, Copp AJ, D\u2019Anna R, Kandaraki E, Greene NDE, Unfer V, Experts Group on Inositol in Basic and Clinical Research (2020) An update on the use of inositols in preventing gestational diabetes mellitus (GDM) and neural tube defects (NTDs). Expert Opin Drug Metab Toxicol 16(12):1187\u20131198. https:\/\/doi.org\/10.1080\/17425255.2020.1828344","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2363_CR97","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/s0002-9378(03)00807-x","volume":"189","author":"PM Groenen","year":"2003","unstructured":"Groenen PM, Peer PG, Wevers RA, Swinkels DW, Franke B, Mariman EC, Steegers-Theunissen RP (2003) Maternal myo-inositol, glucose, and zinc status is associated with the risk of offspring with Spina bifida. Am J Obstet Gynecol 189:1713\u20131719. https:\/\/doi.org\/10.1016\/s0002-9378(03)00807-x","journal-title":"Am J Obstet Gynecol"},{"key":"2363_CR98","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/00001648-200111000-00009","volume":"12","author":"KA Hendricks","year":"2001","unstructured":"Hendricks KA, Nuno OM, Suarez L, Larsen R (2001) Effects of hyperinsulinemia and obesity on risk of neural tube defects among Mexican Americans. Epidemiology 12:630\u2013635. https:\/\/doi.org\/10.1097\/00001648-200111000-00009","journal-title":"Epidemiology"},{"issue":"3","key":"2363_CR99","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/s0002-9378(97)70543-x","volume":"176","author":"EA Reece","year":"1997","unstructured":"Reece EA, Khandelwal M, Wu YK, Borenstein M (1997) Dietary intake of myo-inositol and neural tube defects in offspring of diabetic rats. Am J Obstet Gynecol 176(3):536\u2013539. https:\/\/doi.org\/10.1016\/s0002-9378(97)70543-x","journal-title":"Am J Obstet Gynecol"},{"issue":"8\u20139","key":"2363_CR100","first-page":"469","volume":"27","author":"AS Goldman","year":"1991","unstructured":"Goldman AS, Goto MP (1991) Biochemical basis of the diabetic embryopathy. Isr J Med Sci 27(8\u20139):469\u2013477","journal-title":"Isr J Med Sci"},{"key":"2363_CR101","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/bdra.20454","volume":"82","author":"P Cavalli","year":"2008","unstructured":"Cavalli P, Tedoldi S, Riboli B (2008) Inositol supplementation in pregnancies at risk of apparently folate-resistant NTDs. Birth Defects Res A Clin Mol Teratol 82:540\u2013542. https:\/\/doi.org\/10.1002\/bdra.20454","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"11","key":"2363_CR102","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/bdra.22853","volume":"91","author":"P Cavalli","year":"2011","unstructured":"Cavalli P, Tonni G, Grosso E, Poggiani C (2011) Effects of inositol supplementation in a cohort of mothers at risk of producing an NTD pregnancy. Birth Defects Res A Clin Mol Teratol 91(11):962\u2013965. https:\/\/doi.org\/10.1002\/bdra.22853","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"2363_CR103","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1017\/S0007114515005322","volume":"115","author":"ND Greene","year":"2016","unstructured":"Greene ND, Leung K-Y, Gay V, Burren K, Mills K, Chitty LS, Copp AJ (2016) Inositol for the prevention of neural tube defects: a pilot randomised controlled trial. Br J Nutr 115:974\u2013983. https:\/\/doi.org\/10.1017\/S0007114515005322","journal-title":"Br J Nutr"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02363-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-024-02363-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02363-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T07:28:40Z","timestamp":1725262120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-024-02363-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":103,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["2363"],"URL":"https:\/\/doi.org\/10.1007\/s40618-024-02363-w","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,15]]},"assertion":[{"value":"3 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PM received from Laborest\u00ae the investigational agents for conducting an ongoing research project. The other authors have no conflicting interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}},{"value":"The study does not involve human participants and\/or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human participants or animal rights"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}